Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.36%
1,096.72
+3.98
+0.36%
1,092.741,095.951,103.321,094.72
SIXC
Communications
SIXC
Communications
SIXC
-0.33%
611.32
-2.04
-0.33%
613.36613.36613.36609.50
SIXE
Energy
SIXE
Energy
SIXE
-0.45%
1,171.54
-5.25
-0.45%
1,176.791,176.521,182.251,166.69
SIXI
Industrials
SIXI
Industrials
SIXI
-0.45%
1,747.63
-7.91
-0.45%
1,755.541,759.231,766.301,746.04
SIXM
Financials
SIXM
Financials
SIXM
-0.58%
631.49
-3.66
-0.58%
635.15635.20636.89630.09
SIXR
Staples
SIXR
Staples
SIXR
+0.23%
849.94
+1.93
+0.23%
848.01852.52855.78849.58
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.09%
218.06
+0.20
+0.09%
217.86217.86219.52217.86
SIXT
Technology
SIXT
Technology
SIXT
+3.47%
3,536.03
+118.68
+3.47%
3,417.353,452.773,536.033,450.39
SIXU
Utilities
SIXU
Utilities
SIXU
-0.91%
905.07
-8.29
-0.91%
913.36915.10920.43904.57
SIXV
Health care
SIXV
Health care
SIXV
-0.86%
1,449.86
-12.52
-0.86%
1,462.381,461.131,464.531,446.02
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.30%
2,430.47
+7.33
+0.30%
2,423.142,428.712,448.692,424.63
Q1 2026 earnings • released • EPS beat +3.34% • Revenue miss -32.18%
See results
QURE:NASDAQ
Uniqure NV
$27.66
+14.53%
(+3.51) 1D
$27.77
+0.40% (+0.11)
After hours
Closed: May 8, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for QURE...
Open
$24.30
High
$29.49
Low
$23.49
Mkt. cap
1.74B
Avg. vol.
1.62M
Volume
6.72M
52-wk high
$71.50
52-wk low
$8.73
EPS
-$3.51
Beta
0.87
Shares outstanding
63.07M
No. of employees
221
News stories
From sources across the web
Profile
uniQure is a Dutch biopharmaceutical company which makes gene therapies. It has developed several adeno-associated virus gene therapies. Wikipedia
About Uniqure NV
CEOMatt Kapusta
Employees221
Founded1998
Headquarters-
SectorBiotechnology
Last report
May 5, 2026
Fiscal Period
Q1 2026
EPS / Est. (EUR)
-€0.73 / -€0.75
+3.34%beat
Revenue / Est. (EUR)
3.04M / 4.49M
-32.18%miss
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
5.26M
3.70M
5.57M
3.56M
Cost of goods sold
33.78M
32.25M
40.18M
29.40M
Cost of revenue
33.78M
32.25M
40.18M
29.40M
Research and development expenses
-
695.00K
-5.92M
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
13.50M
19.44M
21.61M
20.07M
Operating expense
13.09M
20.67M
15.55M
16.12M
Total operating expenses
46.87M
52.91M
55.73M
45.51M
Operating income
-41.61M
-49.21M
-50.16M
-41.95M
Other non operating income
-
-7.22M
18.13M
-
EBT including unusual items
-37.29M
-71.90M
-41.00M
-53.05M
EBT excluding unusual items
-35.04M
-70.08M
-40.05M
-53.05M
Income tax expense
425.00K
8.63M
-3.92M
488.00K
Effective tax rate
-1.14%
-12.00%
9.55%
-0.92%
Other operating expenses
-412.00K
534.00K
-143.00K
-3.95M
Net income
-37.72M
-80.53M
-37.09M
-53.54M
Net profit margin
-716.82%
-2,175.87%
-666.06%
-1,502.95%
Earnings per share
-
-
-
-
Interest and investment income
3.52M
3.50M
5.81M
5.23M
Interest expense
-15.59M
-16.72M
-14.57M
-14.03M
Net interest expenses
-12.07M
-13.22M
-8.76M
-8.80M
Depreciation and amortization charges
-
-
-
-
EBITDA
-37.98M
-45.58M
-47.19M
-39.00M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more